357 related articles for article (PubMed ID: 16782240)
1. [Advances in Alzheimer's disease treatment].
Nourhashémi F
Rev Med Interne; 2006 Aug; 27(8):585-7. PubMed ID: 16782240
[No Abstract] [Full Text] [Related]
2. UK government guidance on Alzheimer's drugs postponed.
O'Neill MF
Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
[No Abstract] [Full Text] [Related]
3. Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
Aisen PS
J Am Acad Nurse Pract; 2005 Mar; Suppl():5-7. PubMed ID: 16033023
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacotherapy for Alzheimer's disease].
Verhey FR
Tijdschr Psychiatr; 2006; 48(1):17-26. PubMed ID: 16955982
[TBL] [Abstract][Full Text] [Related]
5. [Are anti-dementia drugs worthwhile?].
Lang CJ
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():85-9. PubMed ID: 17955784
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
[TBL] [Abstract][Full Text] [Related]
7. New drugs for Alzheimer's disease in Japan.
Takeda M; Tanaka T; Okochi M
Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
[No Abstract] [Full Text] [Related]
8. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
Seltzer B
J Int Med Res; 2006; 34(4):339-47. PubMed ID: 16989488
[TBL] [Abstract][Full Text] [Related]
9. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser US; Gasser T
MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
[No Abstract] [Full Text] [Related]
10. [Medical treatment of Alzheimer's disease].
Johannsen P
Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609
[TBL] [Abstract][Full Text] [Related]
11. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Rodda J; Morgan S; Walker Z
Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
[TBL] [Abstract][Full Text] [Related]
12. [Acetylcholinesterase inhibitors for dementia--an update].
Anghelescu I; Heuser I
MMW Fortschr Med; 2007 May; 149 Suppl 2():76-8. PubMed ID: 17724973
[TBL] [Abstract][Full Text] [Related]
13. Dementia medications in palliative care #174.
Morrison LJ; Liao S
J Palliat Med; 2008 May; 11(4):634-5. PubMed ID: 18454618
[No Abstract] [Full Text] [Related]
14. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Prasher VP
Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic management of Alzheimer disease.
Downey D
J Neurosci Nurs; 2008 Feb; 40(1):55-9. PubMed ID: 18330411
[TBL] [Abstract][Full Text] [Related]
17. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study.
Taipale H; Tanskanen A; Koponen M; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2014 Jul; 29(4):216-23. PubMed ID: 24608822
[TBL] [Abstract][Full Text] [Related]
18. [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].
Portela Romero M; Pombo Romero J; Bugarín González R; Tasende Souto M; Represa Veiga S
Rev Esp Salud Publica; 2005; 79(6):665-72. PubMed ID: 16457058
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer disease and its management: a review.
Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
[TBL] [Abstract][Full Text] [Related]
20. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
